Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Arm Phase II Study of Personalized Dose Guidance for Stereotactic Body Radiotherapy (SBRT) in Patients With Lung Tumors

NCT05802186 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT05802186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05802186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Arm Phase II Study of Personalized Dose Guidance for Stereotactic Body Radiotherapy (SBRT) in Patients With Lung Tumors
Lead sponsor
Northwestern University
Phase
Not applicable
Overall status
Recruiting
Start date
November 20, 2023
Completion date
August 1, 2031
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung carcinoma, lung non-small cell carcinoma, metastatic malignant neoplasm in the lung, stage i lung cancer ajcc v8, stage ii lung cancer ajcc v8, stage iiia lung cancer ajcc v8